TGFBR2 and neoplasm: When sequencing the individual metastatic nodules (Fig. S2G and H), we unexpectedly found that Tgfbr2 sgRNA was highly enriched and constituted ~40% of all nodules 3 weeks after tumor injection (Fig. 2F).